Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 2011 Dec 19;208(13):2761. doi: 10.1084/jem.2010189020813c

Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization

Kana Miyamoto, Shigeyuki Yoshida, Miyuri Kawasumi, Kazuaki Hashimoto, Tokuhiro Kimura, Yuiko Sato, Tami Kobayashi, Yoshiteru Miyauchi, Hiroko Hoshi, Ryotaro Iwasaki, Hiroya Miyamoto, Wu Hao, Hideo Morioka, Kazuhiro Chiba, Takashi Kobayashi, Hisataka Yasuda, Josef M Penninger, Yoshiaki Toyama, Toshio Suda, Takeshi Miyamoto
PMCID: PMC3244028

Vol. 208, No. 11, October 24, 2011. Pages 2175–2181.

The authors regret that the dosage of RANKL and control antibodies used in the HSC mobilization experiments shown in Figure 6 were incorrectly reported in micrograms. The correct dosages were 5 mg/kg anti-RANKL and 2.5 mg/kg control antibody. The html and pdf versions of the article have been corrected.


Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES